Sierra Oncology Stock Price - SRRA

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Sierra Oncology Inc SRRA NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 0.3939 0.00 0.00 0.00 0.3939 06:21:55
Bid Price Ask Price Spread Spread % News
0.3747 0.3898 0.0151 3.87% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Sierra Oncology Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 29.42M 74.69M $ -53.34M -0.75 - 74.05M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 0.90%

more financials information »

Sierra Oncology News

Date Time Source News Article
12/07/201909:00PR Newswire (Canada)Sierra Oncology Reports Decreased Transfusion Requirements..
12/06/201907:31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting..
12/03/201916:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
12/03/201916:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
12/03/201916:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
12/03/201916:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
12/02/201917:34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)

Latest SRRA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SRRA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.430.840.360.43460345,847,296-0.0361-8.4%
1 Month0.260.840.200.40932273,964,4670.133951.5%
3 Months0.470.840.200.38570641,620,974-0.0761-16.19%
6 Months0.67990.840.200.4220795996,481-0.286-42.07%
1 Year1.532.100.200.6923838815,918-1.14-74.25%
3 Years1.594.090.201.46580,162-1.20-75.23%
5 Years1.594.090.201.46580,162-1.20-75.23%

Sierra Oncology Description

Sierra Oncology Inc is a clinical-stage drug development company. It focuses on the research, development, and commercialization of DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer in the United States and internationally. The company's lead drug candidate is SRA737, an orally bioavailable small molecule inhibitor of Checkpoint kinase 1, which is in Phase 1 clinical trial to treat patients with advanced cancer. In addition, it also engaged in developing SRA141, an orally bioavailable small molecule inhibitor of the cell division cycle 7 kinase that is in the preclinical development stage.
Your Recent History
Sierra Onc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191212 11:59:15